Explore

Trendline Trendline
Americas Gold and Silver Schedules Q1 2026 Results Call Amidst Strategic Developments

Americas Gold and Silver Schedules Q1 2026 Results Call Amidst Strategic Developments

Americas Gold and Silver Schedules Q1 2026 Results Call Amidst Strategic Developments
Trendline Trendline
Co-Diagnostics to Release Q1 2026 Financial Results, Hosts Webcast for Analysts

Co-Diagnostics to Release Q1 2026 Financial Results, Hosts Webcast for Analysts

Co-Diagnostics to Release Q1 2026 Financial Results, Hosts Webcast for Analysts
Trendline Trendline
Natera to Announce First Quarter 2026 Financial Results, Impacting Stakeholders

Natera to Announce First Quarter 2026 Financial Results, Impacting Stakeholders

Natera to Announce First Quarter 2026 Financial Results, Impacting Stakeholders
Trendline Trendline
Precision BioSciences to Announce Q1 2026 Financial Results, Highlighting Gene Editing Advances

Precision BioSciences to Announce Q1 2026 Financial Results, Highlighting Gene Editing Advances

Precision BioSciences to Announce Q1 2026 Financial Results, Highlighting Gene Editing Advances
Trendline Trendline
Americas Gold and Silver Announces First Quarter 2026 Results and Conference Call

Americas Gold and Silver Announces First Quarter 2026 Results and Conference Call

Americas Gold and Silver Announces First Quarter 2026 Results and Conference Call
Trendline Trendline
Century Casinos Schedules Q1 2026 Earnings Release and Conference Call

Century Casinos Schedules Q1 2026 Earnings Release and Conference Call

Century Casinos Schedules Q1 2026 Earnings Release and Conference Call
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call

Lucid Diagnostics Announces Upcoming Business Update Conference Call

Lucid Diagnostics Announces Upcoming Business Update Conference Call
Trendline Trendline
Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Moderna Reports Q1 2026 Loss Due to Legal Settlement Impact

Moderna Reports Q1 2026 Loss Due to Legal Settlement Impact

Moderna Reports Q1 2026 Loss Due to Legal Settlement Impact
Trendline Trendline
Stoke Therapeutics to Discuss Q1 2026 Financial Updates in Upcoming Webcast

Stoke Therapeutics to Discuss Q1 2026 Financial Updates in Upcoming Webcast

Stoke Therapeutics to Discuss Q1 2026 Financial Updates in Upcoming Webcast
Trendline Trendline
Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion
Trendline Trendline
Keyera Corp. Schedules 2026 First Quarter Results Release and Annual Meeting

Keyera Corp. Schedules 2026 First Quarter Results Release and Annual Meeting

Keyera Corp. Schedules 2026 First Quarter Results Release and Annual Meeting